Healthcare & Pharmaceuticals
The healthcare and pharmaceutical industry in the United States has its primary resources tied up in the form of intangibles. Therefore, the main risk factors of such firms are directly associated with the management of such idiosyncratic resources. Reporting on intangibles has always been controversial because of the persistent conceptual and regulatory challenges, yet voluntary disclosures represent a non-negligible portion of the annual report of such firms.